Based on the in vitro COX-2 inhibitory data, seventeen compounds (Table 2) were selected and further evaluated for their cellular COX-2 inhibitory activity in COX-2 expressing colorectal cancer cell line HCA-7. This evidence concerns the gene PTGS2 and colorectal cancer.